Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for c…
Creates a new tax subchapter that gives large tax credits to medical manufacturers that locate research, production, or component production in designated "economically distressed zones".
Provides a wage/fringe/depreciation credit equal to 40% (higher for certain repatriated or population-health facilities), a purchase credit for goods/services sourced from those zones (30% arm’s-length, 5% related-party), and enhanced allowances and bonus-expensing options for specified repatriated or population-health manufacturing.
Establishes criteria and an application process for designating economically distressed census tracts, includes territories, and sets effective dates; amends public health law to define “population health products,” prioritize vulnerable populations, expand HHS strategic initiatives, require interagency delivery coordination, and require an HHS report to Congress.
Targeted manufacturing incentives and public-health alignment improve prospects, but high fiscal cost, complexity, and need for inter-committee agreement reduce near-term odds.
Relative to its intended legislative type, this bill is a well-structured substantive policy change that creates targeted tax credits and amends public health statutes with clear definitions and operational elements. It specifies core mechanics, eligible activities, and administrative roles while integrating with existing statutory frameworks.
Progressives emphasize jobs and vulnerable-population protections.
Progressives emphasize jobs and vulnerable-population protections.
Generally supportive of using federal incentives to create jobs in high-poverty communities and to secure medical supply chains.
Views the population-health provisions positively for focusing on vulnerable groups.
Concerned about corporate capture and wants stronger labor, environmental, and access safeguards.
Sees pragmatic value in targeted incentives to revive manufacturing and strengthen supply chains, balanced by concerns about fiscal cost and implementation.
Wants transparent metrics, anti-abuse guardrails, and regular evaluation.
Support is conditional on oversight and accountability.
Skeptical of targeted tax credits and expanded federal intervention in industry.
Appreciates job creation and supply-chain security goals but worries about market distortion, fiscal cost, and bureaucratic designation processes.
Likely to push for state control and fewer subsidies.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Targeted manufacturing incentives and public-health alignment improve prospects, but high fiscal cost, complexity, and need for inter-committee agreement reduce near-term odds.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize jobs and vulnerable-population protections.
Targeted manufacturing incentives and public-health alignment improve prospects, but high fiscal cost, complexity, and need for inter-commi…
Relative to its intended legislative type, this bill is a well-structured substantive policy change that creates targeted tax credits and amends public health statutes with clear definitions and operational elements. It…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.